Key result
Confirmed fetal CMV infection accounts for ~4% of fetal demises following positive maternal testing.
Why the study?
Severe congenital CMV can lead to fetal demise, prompting the need to quantify and characterize confirmed CMV infection among fetal demises.
Cohort (n=61,973)
No
CMV infection is a measurable cause of fetal demise, particularly among CMV IgM-positive pregnancies, highlighting the need for improved screening.
Answers are grounded in this paper and cite their sources.
CMV testing may identify cases among fetal demises; leaves open whether routine screening alters outcomes.
Background: CMV is the most common congenital infection worldwide, affecting 0.2–6% of live births and causing significant morbidity and mortality. Although most infections are asymptomatic, severe cases can lead to fetal demise. Objective: To quantify and characterize confirmed CMV infection among fetal demises in a large pediatric hospital in the US from 2013 to 2024. Methods: A retrospective electronic health record (EHR) review of pregnancies with CMV testing, delivery summaries, and confirmed fetal CMV infection via tissue or autopsy linkage. Results: During the review period, 61,973 pregnancies were recorded, with 1173 resulting in fetal demise. Among 1670 pregnancies tested for CMV, 859 had positive testing (e.g., CMV IgG, CMV IgM, CMV DNA), including 96 demises, 94 (11%) of which we had complete delivery records. Four (4%) of these fetal demises were directly attributable to CMV based on positive CMV testing from amniocentesis, fetal tissue, or placenta. Most demises occurred in the second or third trimester (mean gestational age 28.4 ± 6.6 weeks), while the four CMV-attributable cases averaged 23.7 ± 3.7 weeks. Among 93 fetal demise pregnancies in which maternal CMV IgM testing was performed, 9 (9.7%) had a positive CMV IgM result. All confirmed CMV-attributable fetal demises occurred among these CMV IgM-positive pregnancies. Conclusion: These findings underscore CMV’s role in perinatal mortality and highlight the need for improved screening and prevention strategies.
No takes yet. Share an insight, caveat, or question.
Rochat et al. (2026) conducted a cohort in Fetal demise and congenital CMV infection (n=61,973). Maternal CMV infection vs. No maternal CMV infection was evaluated on Fetal demise directly attributable to CMV. Among 94 fetal demises with positive maternal CMV testing and complete records, 4 were directly attributable to confirmed fetal CMV infection.
Synapse has enriched 10 related papers. Consider them for comparative context: